Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells.
Meyer A, Sienes RE, Nijim W, Zanotti B, Umar S, Volin MV, Van Raemdonck K, Lewis M, Pitzalis C, Arami S, Al-Awqati M, Chang HJ, Jetanalin P, Schett G, Sweiss N, Shahrara S.
Meyer A, et al.
Ann Rheum Dis. 2023 Apr;82(4):483-495. doi: 10.1136/ard-2022-223284. Epub 2023 Jan 2.
Ann Rheum Dis. 2023.
PMID: 36593091
Free PMC article.